Cargando…

Aberrant methylation of N-methyl-D-aspartate receptor type 2B (NMDAR2B) in non-small cell carcinoma

BACKGROUND: N-methyl-D-aspartate receptors (NMDAR) act as tumor suppressors of digestive malignancies. The expression and genetic methylation patterns of NMDAR2B in non-small cell lung cancer (NSCLC) are unknown. METHODS: The relationship between gene methylation and expression of NMDAR2B was analyz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tamura, Hajime, Suzuki, Makoto, Moriya, Yasumitsu, Hoshino, Hidehisa, Okamoto, Tatsuro, Yoshida, Shigetoshi, Yoshino, Ichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149028/ https://www.ncbi.nlm.nih.gov/pubmed/21639937 http://dx.doi.org/10.1186/1471-2407-11-220

Ejemplares similares

Roles of N-Methyl-D-Aspartate Receptors (NMDARs) in Epilepsy
por: Chen, Shuang, et al.
Publicado: (2022)

Inhibition of NR2B-Containing N-methyl-D-Aspartate Receptors (NMDARs) in Experimental Autoimmune Encephalomyelitis, a Model of Multiple Sclerosis
por: Farjam, Mojtaba, et al.
Publicado: (2014)

Anti-n-Methyl-d-Aspartate-Receptor (NMDAR) Encephalitis in Association with Ovarian Teratoma
por: Ahmad, Javaad, et al.
Publicado: (2017)

GluN2A and GluN2B N-Methyl-D-Aspartate Receptor (NMDARs) Subunits: Their Roles and Therapeutic Antagonists in Neurological Diseases
por: Ladagu, Amany Digal, et al.
Publicado: (2023)

Current Progress on Assessing the Prognosis for Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Encephalitis
por: Wang, Hao, et al.
Publicado: (2020)

38.3 ONGOING GERMINAL CENTRE REACTIONS CONTRIBUTE TO N-METHYL-D-ASPARTATE RECEPTOR (NMDAR) ANTIBODY PRODUCTION IN NMDAR-ANTIBODY ENCEPHALITIS
por: Makuch, Mateusz, et al.
Publicado: (2018)

Anti N-methyl-D-aspartate receptor (NMDAr) encephalitis during pregnancy: A case report
por: Dono, Fedele, et al.
Publicado: (2022)

Targeting Peripheral N-Methyl-D-Aspartate Receptor (NMDAR): A Novel Strategy for the Treatment of Migraine
por: Kalatharan, Veberka, et al.
Publicado: (2023)

NYX‐2925 induces metabotropic N‐methyl‐d‐aspartate receptor (NMDAR) signaling that enhances synaptic NMDAR and α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid receptor
por: Bowers, M. Scott, et al.
Publicado: (2019)

Case Report: Cotard's Syndrome in Anti-N-methyl D-aspartate (NMDA) Receptor (Anti-NMDAR) Encephalitis
por: Taib, Nur Iwana Abdul, et al.
Publicado: (2022)

Validation of EBUS-TBNA-integrated nodal staging in potentially node-positive non-small cell lung cancer
por: Sakairi, Yuichi, et al.
Publicado: (2013)

Clinical Features, Treatment, and Outcomes Among Chinese Children With Anti-methyl-D-aspartate Receptor (Anti-NMDAR) Encephalitis
por: Zhang, Min, et al.
Publicado: (2019)

Mechanosensitivity of N-methyl-D-aspartate receptors (NMDAR) is the key through which amyloid beta oligomers activate them
por: Fani, Giulia, et al.
Publicado: (2021)

Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Encephalitis Associated With Mediastinal and Ovarian Teratomas: A Case Report
por: Lee, Sue Hyun, et al.
Publicado: (2023)

2-Methylaspartic acid monohydrate
por: Brewer, Greg, et al.
Publicado: (2013)

Prion Protein Is a Key Determinant of Alcohol Sensitivity through the Modulation of N-Methyl-D-Aspartate Receptor (NMDAR) Activity
por: Petit-Paitel, Agnès, et al.
Publicado: (2012)

An Ensemble Approach to Predict Schizophrenia Using Protein Data in the N-methyl-D-Aspartate Receptor (NMDAR) and Tryptophan Catabolic Pathways
por: Lin, Eugene, et al.
Publicado: (2020)

Overlapping anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis with neuromyelitis optica spectrum disorders: a case report
por: Pan, Jialin, et al.
Publicado: (2022)

14-3-3 proteins promote synaptic localization of N-methyl d-aspartate receptors (NMDARs) in mouse hippocampal and cortical neurons
por: Lee, Gloria S., et al.
Publicado: (2021)

Aberrant CBFA2T3B gene promoter methylation in breast tumors
por: Bais, Anthony J, et al.
Publicado: (2004)

Anti-N-methyl-D-aspartate receptor(NMDAR) antibody encephalitis presents in atypical types and coexists with neuromyelitis optica spectrum disorder or neurosyphilis
por: Qin, Kaiyu, et al.
Publicado: (2017)

Pharmacological Comparative Characterization of REL-1017 (Esmethadone-HCl) and Other NMDAR Channel Blockers in Human Heterodimeric N-Methyl-D-Aspartate Receptors
por: Bettini, Ezio, et al.
Publicado: (2022)

NMDAR-Activated PP1 Dephosphorylates GluN2B to Modulate NMDAR Synaptic Content
por: Chiu, Andrew M., et al.
Publicado: (2019)

Association Study of N-Methyl-D-Aspartate Receptor Subunit 2B (GRIN2B) Polymorphisms and Schizophrenia Symptoms in the Han Chinese Population
por: Yang, Yongfeng, et al.
Publicado: (2015)

Anti-N-Methyl-D-Aspartate Receptor Encephalitis after BNT162b2 COVID-19 Vaccination
por: Lee, Hyoung Cheol, et al.
Publicado: (2022)

Study of B Cell Repertoire in Patients With Anti-N-Methyl-D-Aspartate Receptor Encephalitis
por: Feng, Jingjing, et al.
Publicado: (2020)

Portrayal of a young woman in 16(th) century Islamic art: Does she have anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis?
por: Kondziella, Daniel, et al.
Publicado: (2018)

The Spectrum of Movement Disorders in Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Encephalitis Both in Children and Adults: An Experience From a Single Tertiary Care Center
por: Haq, Ayaz Ul, et al.
Publicado: (2021)

Fractalkine (CX(3)CL1) enhances hippocampal N-methyl-d-aspartate receptor (NMDAR) function via d-serine and adenosine receptor type A2 (A(2A)R) activity
por: Scianni, Maria, et al.
Publicado: (2013)

Milnacipran inhibits glutamatergic N-Methyl-D-Aspartate receptor activity in Spinal Dorsal Horn Neurons
por: Kohno, Tatsuro, et al.
Publicado: (2012)

NMDA Receptors in Health and Diseases: New Roles and Signaling Pathways—Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Autoantibodies as Potential Biomarkers of Fatigue in Patients with Rheumatic Diseases
por: Marinoska, Tatjana, et al.
Publicado: (2023)

Preclinical pharmacology and pharmacokinetics of CERC‐301, a GluN2B‐selective N‐methyl‐D‐aspartate receptor antagonist
por: Garner, Rachel, et al.
Publicado: (2015)

Glutamate Attenuates the Survival Property of IGFR through NR2B Containing N-Methyl-D-aspartate Receptors in Cortical Neurons
por: Zhao, Xia, et al.
Publicado: (2020)

A common mechanism allows selective targeting of GluN2B subunit-containing N-methyl-D-aspartate receptors
por: Schreiber, Julian A., et al.
Publicado: (2019)

Development of the Adverse Outcome Pathway (AOP): Chronic binding of antagonist to N-methyl-d-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities of children
por: Sachana, Magdalini, et al.
Publicado: (2018)

Anti-N-methyl-D-aspartate Receptor Encephalitis
por: Tanquary, Gregory, et al.
Publicado: (2019)

Aberrant DNA Methylation in Keratoacanthoma
por: Nobeyama, Yoshimasa, et al.
Publicado: (2016)

DNA Methylation Aberrant in Atherosclerosis
por: Dai, Yao, et al.
Publicado: (2022)

Na(+) Occupancy and Mg(2+) Block of the N-Methyl-d-Aspartate Receptor Channel
por: Zhu, Yongling, et al.
Publicado: (2001)

Comprehensive and quantitative multilocus methylation analysis reveals the susceptibility of specific imprinted differentially methylated regions to aberrant methylation in Beckwith–Wiedemann syndrome with epimutations
por: Maeda, Toshiyuki, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_soph37qlmve3qvl2uihd0ihsf5